OHE submission to the UK Parliamentary Inquiry on an Ageing Society urges UK policy to focus on healthy ageing, adult ...

Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the ...

Earlier this week, President Donald Trump signed an Executive Order to bring the prices Americans and U.S taxpayers pay for prescription drugs in line with those paid by similar nations. “President ...

This calculator is built and hosted by OHE, and owned, funded, and commissioned by Pfizer. Before proceeding, please read the following important information regarding its use. This calculator ...

Rare disease medicine markets often rely on single suppliers, increasing the risk of shortages and limiting treatment options. Our report explores how supplier diversity can enhance healthcare ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the latest data. A previous OHE report in 2019 estimated that 378, 427 people in ...

For the growing number of multi-indication medicines, challenges arise in assessing and paying for value across medicine indications with a uniform price (see our previous report and further ...

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...

Drug shortages are a growing global concern, affecting multiple therapeutic areas. Shortages are often concentrated in generic and biosimilar markets as a result of very low prices. We developed a ...